£10 m program to fast-track cardiometabolic innovation from lab to NHS

Wait 5 sec.

UK-first £10 million UKRI-backed program will take new therapeutics, medical devices and digital health tools for heart disease, diabetes and obesity, from development through real-world validation to adoption in the NHS, private healthcare and international markets.